Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The calcium channel protein alpha1C subunit, also known as CaV1.2, is the pore-forming alpha-1 subunit of the voltage-dependent L-type calcium channel. It mediates influx of Ca²⁺ ions into cells when activated by changes in membrane potential (depolarization), playing a key role in shaping action potentials in cardiac and smooth muscle cells. Mutations or dysregulation are associated with cardiac arrhythmias and psychiatric disorders.
L-type calcium channel antagonist
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium Channel Protein Alpha1C Subunit (CaV1.2).